Infectious Disease

Top Story

Single amoxicillin dose for strep throat allows next-day return to school

September 4, 2015

The majority of students with group A streptococcal pharyngitis treated with a single dose of amoxicillin tested negative for the infection within 24 hours, making them able to return to school the following day, according to a recent study.

“The purpose of this study was to re-evaluate the necessity of the 24-hours of antibiotic treatment for group A streptococcal pharyngitis before permitting return to school,” researcher Richard H. Schwartz, MD, of the department of pediatrics at the Inova Children’s Hospital, Falls Church, Virginia, and colleagues wrote. “We conclude that all children treated with amoxicillin for streptococcal pharyngitis by 5 p.m., if afebrile and improved, may be permitted to attend school on day 2.”

DOD halts operations after anthrax contamination

September 4, 2015
Secretary of the Army John M. McHugh has suspended operations at four laboratories that handle live and inactivated Bacillus anthracis and ordered an…
In the Journals

Probiotics before LT help to prevent infection post-transplant

September 4, 2015
Researchers found that giving probiotics and prebiotics to a patient before liver transplantation successfully reduced the rate of infection post-transplant, according…
Robert Grant In the Journals

Prompt transition between PEP, PrEP, ART benefits HIV patients

September 4, 2015
Immediate transition from post-exposure prophylaxis to pre-exposure prophylaxis and early treatment may prevent the onset of HIV infection and support patient adherence…
Raina N. Fichorova, PhD, MD In the Journals

Hormonal contraceptives, genital tract infections influence cervical immunology

September 4, 2015
Interactions between hormonal contraceptives and various genital tract infections may alter cervical immunity and increase the risk for HIV seroconversion among women…
More News Headlines »

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
At Issue Video
VIDEO: Cure is ‘next frontier’ of HIV

VIDEO: Cure is ‘next frontier’ of HIV

July 1, 2015
Timothy Brown – the Berlin patient – has led researchers to the next frontier of HIV research, according to…
More »
Infectious Disease Case Consults

The Patient with Acute-Bacterial Skin and Skin-Structure Infections

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with acute-bacterial skin and skin-structure…
More »